Hengrui Pharma and Guangdong Provincial People's Hospital presented research findings at the ESMO Congress on October 20, 2026.
1 report, 1 independent
Updated Oct 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Hengrui Pharma and Guangdong Provincial People's Hospital presented research findings at the ESMO Congress on October 20, 2026.
Who's involved
What this event is mainly aboutEuropean Society for Medical OncologyGuangdong Provincial People's Hospital
Keep exploring
The entities involved
-
European Society for Medical Oncology
Professional organisation
Related events
- AstraZeneca presented trial results at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.
- Researchers presented Phase 3 clinical data at the European Society for Medical Oncology (ESMO) Congress on September 21, 2026.
- Study results were presented by Tempus and Pfizer at the ESMO Congress, focusing on ongoing collaboration regarding diagnostic barriers.
- Zai Lab Limited presented clinical data at the ESMO Congress 2026 in Cambridge, Mass.
- Abbott presented clinical data and collaborated with Dr. Takayuki Yoshino at the ESMO Congress.